Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Single-versus multi-port robotic partial nephrectomy: a meta-analytic study of perioperative, functional, and oncologic outcomes.

Journal of robotic surgery·2026
Same author

Single-versus multi-port robotic partial nephrectomy: a meta-analytic study of perioperative, functional, and oncologic outcomes.

Journal of robotic surgery·2026
Same author

Operative approaches and outcomes of nephroureterectomy for UTUC: a network meta-analysis.

Journal of robotic surgery·2026
Same author

Learning curve's impact on positive surgical margins in RALRP: A prospective cohort study and meta-analysis.

The French journal of urology·2025
Same author

Direct head-to-head comparison between neoadjuvant and adjuvant chemotherapy in upper tract urothelial carcinoma: A systematic review and meta-analysis.

Urologia·2025
Same author

Uncovering the Rare: A Systematic Review and Patient-level Meta-analysis of Testicular Metastases From Renal Cell Carcinoma.

Urology·2025

Related Experiment Video

Updated: Jul 12, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K

Prognostic Markers and Trials in Penile Cancer.

Naufal Naushad1, Abdalla A Deb2, Ayman A Agag3

  • 1Department of Urology, Christie NHS Foundation Trust, Manchester, UK.

Urology Research & Practice
|October 25, 2023
PubMed
Summary

New tumor biomarkers offer personalized treatment for penile cancer. However, conflicting research necessitates further investigation before clinical application for penile squamous cell carcinoma management.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

Related Experiment Videos

Last Updated: Jul 12, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

Area of Science:

  • Oncology
  • Urology
  • Cancer Biomarkers

Background:

  • Penile squamous cell carcinoma (PSCC) management is evolving with the identification of novel tumor biomarkers.
  • Existing biomarker research for PSCC shows promise but suffers from inconsistent findings and requires further validation.
  • The clinical utility of biomarkers in tailoring PSCC therapy remains under investigation.

Purpose of the Study:

  • To review prominent and emerging biomarkers for penile cancer.
  • To summarize current clinical trials focused on penile cancer patient management.
  • To provide an overview of the potential for biomarker-driven personalized medicine in PSCC.

Main Methods:

  • This study employed a narrative review methodology.
  • Literature search focused on commonly and recently investigated penile cancer biomarkers.
  • Included a summary of registered clinical trials for penile cancer treatment.

Main Results:

  • Several biomarkers show potential for PSCC diagnosis and prognosis.
  • Contradictory results exist for some biomarkers, highlighting the need for robust validation.
  • A number of clinical trials are actively investigating novel therapeutic strategies for penile cancer.

Conclusions:

  • Biomarker discovery is crucial for advancing personalized therapy in penile cancer.
  • Further rigorous research is essential to resolve current controversies and establish biomarker reliability.
  • Integrating validated biomarkers into clinical practice could significantly improve PSCC patient outcomes.